Showing 1,441 - 1,460 results of 64,888 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (we decrease)) ))', query time: 1.13s Refine Results
  1. 1441

    Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  2. 1442
  3. 1443

    Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues by Lindsay B. Tulloch (1266861)

    Published 2017
    “…We show that (i) <b>compound 1</b> decreases cellular ATP levels (ii) by inhibiting oxidative phosphorylation (iii) at the F<sub>o</sub>F<sub>1</sub>-ATP synthase. …”
  4. 1444
  5. 1445

    Flibanserin’s neuroprotective effects are 5-HT<sub>1A</sub> receptor-mediated. by Aaron S. Coyner (2889722)

    Published 2016
    “…A 6 mg/kg dose of flibanserin in 5-HT<sub>1A</sub> knockout mice (5-HT1A KO + 6 mg/kg Flibanserin, <i>red</i>) resulted in average receptor plus thickness that was not significantly different from vehicle-injected and naïve mice. …”
  6. 1446
  7. 1447
  8. 1448
  9. 1449
  10. 1450
  11. 1451
  12. 1452
  13. 1453

    Flowchart of patients. by Seydou Goro (17847203)

    Published 2024
    “…Mortality at 30 days was 3.6% and we found that the mortality decreases with increasing of the hospital activity. …”
  14. 1454
  15. 1455
  16. 1456

    Initial treatment regimen. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  17. 1457

    Patients baseline characteristics. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  18. 1458

    Overall survival. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  19. 1459

    Progression-free survival by treatment. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  20. 1460

    Maintenance regimen and adverse event management. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”